ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Revenue of ShockWave Medical, Inc. (SWAV)
Revenue in 2023 (TTM): $730.23 M
According to ShockWave Medical, Inc.'s latest financial reports the company's current revenue (TTM) is $730.23 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of ShockWave Medical, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $730.23 M | $634.84 M | $176.35 M | $174.28 M | $147.28 M |
| 2022 | $489.73 M | $424.74 M | $127.57 M | $120.83 M | $216 M |
| 2021 | $237.15 M | $195.71 M | $-871,000 | $-8,835,000 | $-9,136,000 |
| 2020 | $67.79 M | $46.8 M | $-62,317,000 | $-65,619,000 | $-65,699,000 |
| 2019 | $42.93 M | $25.77 M | $-49,558,000 | $-51,047,000 | $-51,109,000 |
| 2018 | $12.26 M | $5.01 M | $-39,911,000 | $-41,064,000 | $-41,102,000 |
| 2017 | $1.72 M | $-1,117,000 | $-30,031,000 | $-30,589,000 | $-30,615,000 |